Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

Dianabol and LGD-4033 Interaction: Avoid | Peptide Database

Compound Profiles Dianabol Oral Anabolic Steroid | Classic Mass Builder Dianabol exerts its effects primarily through binding to the androgen receptor (AR), promoting nitrogen retention, protein synthesis, and glycogenolysis in skeletal muscle tissue. Its 17-a

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

Compound Profiles

Dianabol

Oral Anabolic Steroid | Classic Mass Builder

Dianabol exerts its effects primarily through binding to the androgen receptor (AR), promoting nitrogen retention, protein synthesis, and glycogenolysis in skeletal muscle tissue. Its 17-alpha-alkylated structure allows it to survive first-pass hepatic metabolism, enabling oral bioavailability but placing significant stress on the liver.

LGD-4033

Selective Androgen Receptor Modulator | Lean Mass

LGD-4033 binds to the androgen receptor with high affinity (Ki of approximately 1 nM), functioning as a potent and selective agonist in muscle and bone tissue. Like other SARMs, its tissue selectivity is mediated by differential cofactor recruitment: upon binding to the AR, LGD-4033 induces a receptor conformation that preferentially recruits coactivators expressed in skeletal muscle and bone, while showing minimal agonist activity in androgen-sensitive tissues such as the prostate and skin.

Combined Organ Load

Shared Safety Flags

Frequently Asked Questions

Can I take Dianabol with LGD-4033?

Combining Dianabol with LGD-4033 is not recommended. Both Dianabol and LGD-4033 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Dianabol and LGD-4033 safe together?

This combination carries significant risk. Both Dianabol and LGD-4033 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Dianabol and LGD-4033?

Both Dianabol and LGD-4033 carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 64% confidence and is inferred from pharmacological mechanism analysis.

How should I time Dianabol and LGD-4033?

Dianabol has a half-life of ~4-6 hours and LGD-4033 has a half-life of ~24-36 hours. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

comparison

What's the addiction risk of phenibut vs benzodiazepines?

Phenibut carries similar addiction and withdrawal risk to benzodiazepines despite not being a benzo. Physical dependence can develop in as little as 1-2 weeks of daily use, and withdrawal i…

Source: peptide-db.com
comparison

Why is TB-500 dosed 2.5x higher in Tri-Heal Max versus standard Wolverine Stack?

Tri-Heal Max emphasizes TB-500's superior cell migration and angiogenesis properties (25mg vs standard 10mg) for more significant tissue damage. The 2.5:1 ratio targets acute injuries, majo…

Source: peptide-db.com
comparison

BPC-157 vs TB-500: Mechanisms, Dosing & the Wolverine Stack

How BPC-157 and TB-500 compare for healing: mechanism differences, dosing protocols, clinical evidence, and when to combine both in the Wolverine Stack.

Source: peptide-db.com
Research context

Read sources and limitations before applying a claim.

Research Indications

GLORY-2 demonstrated 20.1% weight loss with 9mg over 60 weeks; 48.7% achieved ≥20% reduction. Significant reductions in waist circumference, systolic BP (-7.57 mmHg), triglycerides (-43%). Exploratory analysis showed 80.2% reduction in liver fat, suggesting MASLD/MASH benefits. HbA1c reductions of 1.41-2.03% across trials; DREAMS-3 showed -2.03% vs semaglutide -1.84%. 48% achieved HbA1c <7.0% AND ≥10% weight loss versus 21% with semaglutide. Systolic reduction of -7.57 mmHg, diastolic -2.98 mmHg in clinical trials. Total cholesterol -16.82%, triglycerides -43.29%, LDL -17.07%.

Source: peptide-db.com ↗

Research Indications

Standard Selank approved in Russia for GAD; NA-Selank Amidate offers enhanced delivery. Modulates stress response through GABA and serotonin systems without sedation. Improves mood through serotonin metabolism activation. Increases memory trace stability for up to 30 days in animal studies. BDNF elevation supports learning and neuroplasticity. BDNF increase reduces effects of neurological injury. Based on tuftsin structure, retains immunomodulatory properties.

Source: peptide-db.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

Dosage reference

Dosing Protocols

Tretinoin is used exclusively as a topical medication, available in cream, gel, and microsphere gel formulations at concentrations ranging from 0.01% to 0.1%. It is applied once nightly to clean, dry skin. The cream formulation is generally better tolerated and more moisturizing, while gel formulations are preferred for oily or acne-prone skin. Microsphere (Retin-A Micro) technology provides controlled release, reducing irritation. A pea-sized amount is sufficient for the entire face. Application should be followed by a moisturizer if needed, and broad-spectrum sunscreen is mandatory during the day. Beginner / Acclimation phase 0.025% cream Every other night or 2-3 nights per week for 2-4 weeks, then nightly Topical application to face Standard anti-aging and acne treatment 0.05% cream or gel Once nightly Maximum strength (experienced users / resistant acne) 0.1% cream or gel Reduced irritation formulation 0.04% or 0.08% microsphere gel (Retin-A Micro)

Source: peptide-db.com ↗
Side effects

Common Side Effects

Gastrointestinal distress (diarrhea, cramping, bloating, nausea, flatulence) - most frequent complaint, affecting 10-15% of users, especially at higher doses or without food Constipation (less common than diarrhea but reported by some users) Decreased appetite Mild abdominal discomfort, particularly during the first 1-2 weeks of use

Source: peptide-db.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →

Continue learning

Related guides